Effects of Water-soluble Olive Extract Supplementation
Sponsor
University of Texas at Austin (Other)
Overall Status
Completed
CT.gov ID
NCT01113827
Collaborator
DSM Nutritional Products, Inc. (Industry)
61
1
3
24
2.5
Study Details
Study Description
Brief Summary
Six weeks of supplementation of an olive extract will:
-
Improve antioxidant status
-
Reduce inflammation
-
Reduce muscle damage
-
Improve exercise performance
-
Improve exercise recovery as compared to a placebo.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
61 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Effects of Water-soluble Olive Extract on Antioxidant Status, Exercise Performance, Muscle Metabolism, Muscle Damage and Inflammation
Study Start Date
:
Feb 1, 2010
Actual Primary Completion Date
:
Jul 1, 2011
Actual Study Completion Date
:
Feb 1, 2012
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: 150mg olive extract
|
Dietary Supplement: Olive Extract
Capsule form ingested 1x/day for 6 weeks
|
| Active Comparator: 50mg olive extract
|
Dietary Supplement: Olive Extract
Capsule form ingested 1x/day for 6 weeks
|
| Placebo Comparator: Placebo control
|
Dietary Supplement: Placebo
Placebo
|
Outcome Measures
Primary Outcome Measures
- Improved Antioxidant Status [6 weeks]
Secondary Outcome Measures
- Reduced Inflammation [6 weeks]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Recreational exerciser
-
BMI <= 30
-
Non-smoker
Exclusion Criteria:
-
Blood pressure over 140/90
-
Type I or Type II diabetes
-
Renal, hepatic or cardiac disease
-
Current infectious disease
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | The University of Texas at Austin | Austin | Texas | United States | 78712 |
Sponsors and Collaborators
- University of Texas at Austin
- DSM Nutritional Products, Inc.
Investigators
- Principal Investigator: John Ivy, Ph.D., The University of Texas at Austin
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT01113827
Other Study ID Numbers:
- 2009-09-01-OLIV
First Posted:
Apr 30, 2010
Last Update Posted:
Mar 27, 2012
Last Verified:
Feb 1, 2012
Keywords provided by University of Texas at Austin